| Cardiac Valve Diseases and Treatments | Lifetime | 51 | DE 3 | 99.86 |
| Infective Endocarditis Diagnosis and Management | Lifetime | 36 | DE 4 | 99.80 |
| Cardiac Structural Anomalies and Repair | Lifetime | 131 | DE 9 | 99.53 |
| Angiogenesis and VEGF in Cancer | Lifetime | 170 | DE 15 | 98.81 |
| Hormonal Regulation and Hypertension | Lifetime | 240 | DE 27 | 98.70 |
| Cardiovascular Function and Risk Factors | Lifetime | 482 | DE 23 | 99.12 |
| Renin-Angiotensin System Studies | Lifetime | 98 | DE 17 | 98.74 |
| Receptor Mechanisms and Signaling | Lifetime | 687 | DE 35 | 98.39 |
| Atherosclerosis and Cardiovascular Diseases | Lifetime | 270 | DE 15 | 98.00 |
| Atrial Fibrillation Management and Outcomes | Lifetime | 823 | DE 68 | 98.11 |
| Cardiac Arrhythmias and Treatments | Lifetime | 834 | DE 56 | 98.01 |
| Lipoproteins and Cardiovascular Health | Lifetime | 539 | DE 15 | 97.81 |
| Aortic Disease and Treatment Approaches | Lifetime | 587 | DE 55 | 97.67 |
| Extracellular vesicles in disease | Lifetime | 621 | DE 25 | 95.55 |
| Cardiac pacing and defibrillation studies | Lifetime | 909 | DE 57 | 97.45 |
| Antiplatelet Therapy and Cardiovascular Diseases | Lifetime | 799 | DE 51 | 96.72 |
| Cardiac tumors and thrombi | Lifetime | 738 | DE 30 | 94.17 |
| Cardiac and Coronary Surgery Techniques | Lifetime | 804 | DE 70 | 94.26 |
| Lymphatic System and Diseases | Lifetime | 398 | DE 22 | 92.64 |
| Aortic Thrombus and Embolism | Lifetime | 592 | DE 32 | 70.38 |
| Cardiac Valve Diseases and Treatments | 2021-2025 | 26 | DE 6 | 99.79 |
| Infective Endocarditis Diagnosis and Management | 2021-2025 | 33 | DE 9 | 99.55 |
| Cardiovascular Function and Risk Factors | 2021-2025 | 124 | DE 9 | 99.14 |
| Cardiac Structural Anomalies and Repair | 2021-2025 | 78 | DE 13 | 98.72 |
| Aortic Disease and Treatment Approaches | 2021-2025 | 215 | DE 21 | 96.05 |
| Atrial Fibrillation Management and Outcomes | 2021-2025 | 886 | DE 78 | 94.18 |
| Cardiac Arrhythmias and Treatments | 2021-2025 | 712 | DE 67 | 94.65 |
| Cardiac pacing and defibrillation studies | 2021-2025 | 936 | DE 74 | 90.62 |
| Cardiac tumors and thrombi | 2021-2025 | 414 | DE 26 | 79.37 |
| Aortic Thrombus and Embolism | 2021-2025 | 73 | DE 3 | 65.24 |
| Cardiac and Coronary Surgery Techniques | 2021-2025 | 837 | DE 79 | 65.30 |
| Sphingolipid Metabolism and Signaling | 2021-2025 | 756 | DE 73 | 57.51 |
| Pericarditis and Cardiac Tamponade | 2021-2025 | 659 | DE 16 | 55.32 |
| Dermatological and Skeletal Disorders | 2021-2025 | 514 | DE 46 | 54.59 |
| Vitamin K Research Studies | 2021-2025 | 685 | DE 59 | 24.50 |